Brief: Mendus Says Vididencel Combination Potential Confirmed
13/05/2026 07:07
May 13 (Reuters) - Mendus AB (publ) IMMUN.ST: PRECLINICAL DATA PRESENTED AT CIMT CONFIRM COMBINATION POTENTIAL OF VIDIDENCEL WITH CURRENT AND UPCOMING CML TREATMENTS Source text: ID:nMFN1HknPj Further company coverage: IMMUN.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))